| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/01/2013 | CN103080085A Novel crystalline forms of 4,4'-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1H-indole-1,3-diyl]dibutanoic acid, 4,4'-[2-methyl-7-({4-[4-(pentafluorophenyl)butoxy]phenyl}ethynyl)-1H-indole-1,3-diyl]dibutanoic acid, and 4,4'-[4-fluoro-2-methyl-7-({4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl}ethynyl)-1H-indole-1,3-diyl]dibutanoic acid |
| 05/01/2013 | CN103074339A Nucleic acid and medicine composition, and application thereof |
| 05/01/2013 | CN103071141A Traditional Chinese medicament composition for treating neonatal scleredema |
| 05/01/2013 | CN103071130A Traditional Chinese medicine for curing chronic spleen wind |
| 05/01/2013 | CN103070934A Summer health-care foot washing liquor and preparation method thereof |
| 05/01/2013 | CN102274415B Chinese medicinal composition for treating consumptive disease |
| 05/01/2013 | CN101809005B Fused bicyclic compound |
| 05/01/2013 | CN101646446B Rankl产生抑制剂 Rankl production inhibitors |
| 05/01/2013 | CN101558038B Curcumin derivative |
| 04/30/2013 | USRE44186 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
| 04/30/2013 | US8431605 Modulators of ATP-binding cassette transporters |
| 04/30/2013 | US8431589 2,4-diaminopyrimidine derivatives |
| 04/30/2013 | US8431543 Chitosan based polymer conjugate and a method for producing the same |
| 04/30/2013 | US8431400 Dermal sheath cup cell population |
| 04/30/2013 | US8431380 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/30/2013 | US8431159 Solid pharmaceutical dispersions with enhanced bioavailability |
| 04/30/2013 | US8431154 Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient |
| 04/30/2013 | US8431124 Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP) |
| 04/30/2013 | US8431121 Specifically targeted catalytic antagonists and uses thereof |
| 04/30/2013 | CA2514921C Combined use of olmesartan medoxomil and azelnidipine or amlodipine for the treatment of arteriosclerosis and hypertension |
| 04/30/2013 | CA2452491C Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 04/30/2013 | CA2435664C Ncc2705-the genome of a bifidobacterium |
| 04/30/2013 | CA2417495C Methods for treating cell proliferative disorders and viral infections |
| 04/30/2013 | CA2412612C Eg-vegf nucleic acids and polypeptides and methods of use |
| 04/30/2013 | CA2399321C Adenovirus formulations |
| 04/30/2013 | CA2383154C Baff receptor (bcma), an immunoregulatory agent |
| 04/30/2013 | CA2365742C Formulations for amylin agonist peptides |
| 04/25/2013 | WO2013058344A1 Method for predicting effect of plk1 inhibitor |
| 04/25/2013 | WO2013058303A1 Medicinal composition |
| 04/25/2013 | WO2013058294A1 Therapeutic agent for pancreatic cancer and/or biliary tract cancer |
| 04/25/2013 | WO2013058258A1 Bicyclic heterocyclic compound |
| 04/25/2013 | WO2013058194A1 Srf signal activating agent |
| 04/25/2013 | WO2013057944A1 Novel spiroindoline compound, and medicinal agent comprising same |
| 04/25/2013 | US20130104253 Cytoplasmic transfer to de-differentiate recipient cells |
| 04/25/2013 | US20130102555 Method of treating diabetes |
| 04/25/2013 | US20130102495 Sperm-Specific Cation Channel, Catsper1 and Uses Therefor |
| 04/25/2013 | US20130102073 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 04/25/2013 | US20130101671 Polypeptide for treating or preventing adhesions |
| 04/25/2013 | CA2852618A1 Pharmaceutical composition |
| 04/25/2013 | CA2851589A1 Bicyclic heterocyclic compound |
| 04/24/2013 | EP2583967A1 Crystal of amide compound |
| 04/24/2013 | EP2583964A1 Novel crystalline forms of 4,4'-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl}ethynyl)-2-methyl-1h-indole-1,3-diyl]dibutanoic acid, 4,4'-[2-methyl-7-({4-[4-(pentafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid, and 4,4'-[4-fluoro-2-methyl-7-({4-[4-(2,3,4,6-tetrafluorophenyl)butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid |
| 04/24/2013 | EP2583693A1 Pharmaceutical composition utilizing pancreatic cell proliferation factor |
| 04/24/2013 | EP2583691A1 Agent for treating renal fibrosis |
| 04/24/2013 | EP2583686A1 Agent for reducing acetaldehyde in oral cavity |
| 04/24/2013 | EP2583675A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism |
| 04/24/2013 | CN1869061B Peptidomimetic protease inhibitors |
| 04/24/2013 | CN103068816A Crystal of amide compound |
| 04/24/2013 | CN103068807A Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound |
| 04/24/2013 | CN103068403A Method and composition for treating, preventing and diagnosing cancer containing cancer stem cells or derived therefrom |
| 04/24/2013 | CN103068402A Composition for regeneratng normal tissue from fibrotic tissue |
| 04/24/2013 | CN103068381A Medicinal agent for prevention and/or treatment of hepatocellular carcinoma |
| 04/24/2013 | CN103055306A Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies |
| 04/24/2013 | CN103055296A Chinese medicine formula for treating hidrosis |
| 04/24/2013 | CN103055231A Method for preparing traditional Chinese medicine preparation |
| 04/24/2013 | CN103055145A Traditional Chinese medicine composition for repairing organs |
| 04/24/2013 | CN103055061A Chinese medicine preparation for treating hidrosis |
| 04/24/2013 | CN103054843A Application of altenusin compound and pharmaceutically acceptable salt thereof in preparation of medicaments for treating FXR-mediated diseases |
| 04/24/2013 | CN102337268B Human CTRP4 gene, its coding protein and their application |
| 04/24/2013 | CN102335422B Recombinant phage peculiar smell removal vaccine for boars |
| 04/24/2013 | CN101979093B Composition comprising polypeptide-drug substance and other poorly absorbed active ingredient and its use |
| 04/24/2013 | CN101643789B RNA interference mediating small RNA molecules |
| 04/24/2013 | CN101558071B Substituted quinazolines |
| 04/24/2013 | CN101503408B 8-(3-amino-piperidin-1-yl)-xanthines |
| 04/24/2013 | CN101374508B Novel nitrocatechol derivatives having selectin ligand activity |
| 04/23/2013 | US8426588 Phenylalanine derivatives |
| 04/23/2013 | US8426573 Nucleic acids encoding TNFγ |
| 04/23/2013 | US8426468 Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism |
| 04/23/2013 | US8426426 Gyrase inhibitors and uses thereof |
| 04/23/2013 | US8426198 In vitro differentiated cell and human embryonic stem cell population |
| 04/23/2013 | US8426147 RORS as modifiers of the p21 pathway and methods of use |
| 04/23/2013 | US8425939 Remedy |
| 04/23/2013 | US8425908 Treatment with anti-ErbB2 antibodies |
| 04/23/2013 | CA2694567C Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |
| 04/23/2013 | CA2658361C Ophthalmic formulations for the treatment of inflammation |
| 04/23/2013 | CA2555712C Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein |
| 04/23/2013 | CA2473212C Pharmaceutical composition which improves in vivo gene transfer |
| 04/23/2013 | CA2471355C Substituted diketopiperazines as oxytocin antagonists |
| 04/18/2013 | WO2013054830A1 Monoclonal antibody against el, inhibiting el enzymatic activity |
| 04/18/2013 | WO2013054770A1 Anemia of cancer improving / prophylactic agent |
| 04/18/2013 | WO2013054765A1 Improving / prophylactic agent for chronic kidney disease |
| 04/18/2013 | WO2013054756A1 Treatment agent and/or prophylactic agent for side effects of cancer drugs |
| 04/18/2013 | WO2013054755A1 Erythropoietin production-promoting agent |
| 04/18/2013 | WO2013053206A1 Quinazoline derivatives as kinases inhibitors and methods of use thereof |
| 04/18/2013 | WO2013053021A1 ANTIBODIES TO CD1d |
| 04/18/2013 | US20130096137 Treating Sexual Desire Disorders with Flibanserin |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
| 04/18/2013 | US20130096073 Casein Derived Peptides And Uses Thereof |
| 04/18/2013 | US20130095569 Pregnancy-associated plasma protein-a2 (papp-a2) polynucleotides |
| 04/18/2013 | US20130095482 Methods of detecting pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/18/2013 | US20130095032 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 04/18/2013 | CA2850961A1 Antibodies to cd1d |
| 04/17/2013 | EP2581370A1 Crystals of di(arylamino)aryl compound |
| 04/17/2013 | EP1600141B1 Collagenolytic active enzyme containing compositions for the treatment of dental caries |
| 04/17/2013 | CN103052396A Use of plant or like for improving pores, method for improving pores and oral preparation for improving pores |
| 04/17/2013 | CN103052391A Pyrroloquinoline quinone gel |
| 04/17/2013 | CN103052386A Composition containing tetracyclic compound |
| 04/17/2013 | CN103045597A Small nucleotide hsa-miR-1909 and application thereof |
| 04/17/2013 | CN103045545A Encephalitis virus protein, and coding gene and application thereof |
| 04/17/2013 | CN103044554A Human urinary trypsin inhibitor (hUTI) of reorganization-dimerization and preparation method and application thereof |